【亚虹医药(688176.SH)：实控人及财务负责人完成增持耗资400万元】智通财经APP讯，亚虹医药(688176.SH)公告，截至2024年7月2日，公司控股股东、实际控制人、董事长兼总经理PAN KE，董事、董事会秘书兼财务负责人杨明远累计增持公司股份67.

智通财经07-02

【亚虹医药(688176.SH)：实控人及财务负责人完成增持耗资400万元】智通财经APP讯，亚虹医药(688176.SH)公告，截至2024年7月2日，公司控股股东、实际控制人、董事长兼总经理PAN KE，董事、董事会秘书兼财务负责人杨明远累计增持公司股份67.40万股，占公司总股本的0.1183%，增持金额合计人民币400.05万元，截至目前，增持金额已达到并超过本次增持计划拟增持金额...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2448139202?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-02 18:21","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2448139202","market":"us","top_or_hot":-1,"title":"【亚虹医药(688176.SH)：实控人及财务负责人完成增持 耗资400万元】智通财经APP讯，亚虹医药(688176.SH)公告，截至2024年7月2日，公司控股股东、实际控制人、董事长兼总经理PAN KE，董事、董事会秘书兼财务负责人杨明远累计增持公司股份67.","media":"智通财经","content":"<div>\n<p>【亚虹医药(688176.SH)：实控人及财务负责人完成增持 耗资400万元】智通财经APP讯，亚虹医药(688176.SH)公告，截至2024年7月2日，公司控股股东、实际控制人、董事长兼总经理PAN \n\nKE，董事、董事会秘书兼财务负责人杨明远累计增持公司股份67.40万股，占公司总股本的0.1183%，增持金额合计人民币400.05万元，截至目前，增持金额已达到并超过本次增持计划拟增持金额...</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=astock\">网页链接</a>\n\n</div>\n","source":"live_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7x24快讯</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7x24快讯\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-02 18:21 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.zhitongcaijing.com/immediately.html?type=astock><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【亚虹医药(688176.SH)：实控人及财务负责人完成增持 耗资400万元】智通财经APP讯，亚虹医药(688176.SH)公告，截至2024年7月2日，公司控股股东、实际控制人、董事长兼总经理PAN \n\nKE，董事、董事会秘书兼财务负责人杨明远累计增持公司股份67.40万股，占公司总股本的0.1183%，增持金额合计人民币400.05万元，截至目前，增持金额已达到并超过本次增持计划拟增持金额...</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=astock\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KE","symbol_name":"Kimball Electronics, Inc.","start_time":0,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","article_id":"2448139202","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2448139202","pubTimestamp":1719915702,"sourceInfo":{"source_id":"live_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"【亚虹医药(688176.SH)：实控人及财务负责人完成增持 耗资400万元】智通财经APP讯，亚虹医药(688176.SH)公告，截至2024年7月2日，公司控股股东、实际控制人、董事长兼总经理PA","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688176":"亚虹医药","KE":"Kimball Electronics, Inc.","BK0239":"医药制造","BK4145":"电子制造服务"},"translate_title":"[Yahong Pharmaceutical (688176. SH): The actual controller and financial controller completed the increase in holdings at a cost of 4 million yuan] Zhitong Finance APP News, Yahong Pharmaceutical (688176. SH) announced that as of July 2, 2024, the company's controlling shareholder, actual controller, chairman and general manager PAN KE, and director, secretary of the board of directors and financial controller Yang Mingyuan increased their holdings of the company's shares by a total of 67.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688176":1,"KE":1},"content_text":"【亚虹医药(688176.SH)：实控人及财务负责人完成增持 耗资400万元】智通财经APP讯，亚虹医药(688176.SH)公告，截至2024年7月2日，公司控股股东、实际控制人、董事长兼总经理PAN \n\nKE，董事、董事会秘书兼财务负责人杨明远累计增持公司股份67.40万股，占公司总股本的0.1183%，增持金额合计人民币400.05万元，截至目前，增持金额已达到并超过本次增持计划拟增持金额区间下限400万元，本次增持股份计划已实施完毕。","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2448139202"}